Novartis promises a speedy CAR-T pitch, boasts about its slate of blockbusters-to-be
Novartis sent out a loud and clear message this morning: Despite folding its standalone cell therapy unit, the pharma giant says it remains on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
